Axonics, Inc. (AXNX) Financial Statements (2024 and earlier)

Company Profile

Business Address 26 TECHNOLOGY DRIVE
IRVINE, CA 92618
State of Incorp. DE
Fiscal Year End December 31
Industry (SIC) 3841 - Surgical and Medical Instruments and Apparatus (benchmarking)
More info Complete Financial Analysis Financial Benchmarking

Balance Sheet (Statement of Financial Position) ($ in thousands)

12/31/2023
Q4
9/30/2023
Q3
6/30/2023
Q2
3/31/2023
Q1
12/31/2022
Q4
9/30/2022
Q3
6/30/2022
Q2
ASSETS
Current Assets
Cash, cash equivalents, and short-term investments, including:344,700331,500357,100357,211350,000213,200
Cash and cash equivalents147,323145,343240,105238,846241,331203,236
Short-term investments197,393186,173116,957118,365108,6829,998
Other undisclosed cash, cash equivalents, and short-term investments (16)(16)38 (13)(34)
Receivables48,94447,43640,20044,81736,96036,115
Inventory, net of allowances, customer advances and progress billings74,90970,08366,06755,76557,82758,412
Inventory74,90970,08366,06755,76557,82758,412
Other undisclosed current assets6,8326,3776,3047,2824,5745,400
Total current assets:475,385455,396469,671465,075449,361313,127
Noncurrent Assets
Operating lease, right-of-use asset      
Property, plant and equipment 6,5566,3497,0176,7987,1037,228
Intangible assets, net (including goodwill)175,561184,423182,469180,667168,729186,479
Goodwill95,28798,88096,58194,41486,94294,852
Intangible assets, net (excluding goodwill)80,27485,54385,88886,25381,78791,627
Other noncurrent assets3,2452,8176,5346,8137,0857,254
Other undisclosed noncurrent assets      
Total noncurrent assets:185,362193,589196,020194,278182,917200,961
TOTAL ASSETS:660,747648,985665,691659,353632,278514,088
LIABILITIES AND EQUITY
Liabilities
Current Liabilities
Accounts payable and accrued liabilities20,62817,75621,37715,59028,82028,430
Employee-related liabilities11,74210,922
Accounts payable14,66612,18514,7379,0709,97210,207
Accrued liabilities5,9625,5716,6406,5207,1067,301
Other liabilities   34,40032,60030,500 
Other undisclosed current liabilities14,96514,32810,39317,0571,5231,429
Total current liabilities:35,59332,08466,17065,24760,84329,859
Noncurrent Liabilities
Long-term debt and lease obligation:     7,9608,321
Liabilities, other than long-term debt14,53416,37222,91523,96713,95738,182
Deferred income tax liabilities13,65815,17315,73716,41213,95715,782
Other liabilities      22,400
Operating lease, liability8761,1997,1787,5557,9608,321
Total noncurrent liabilities:14,53416,37222,91523,96721,91746,503
Total liabilities:50,12748,45689,08589,21482,76076,362
Equity
Equity, attributable to parent610,620600,529576,606570,139549,518437,726
Common stock555555
Additional paid in capital1,022,0521,009,704982,189969,545960,627820,526
Accumulated other comprehensive loss(24,511)(18,326)(22,076)(25,147)(36,185)(24,128)
Accumulated deficit(386,926)(390,854)(383,512)(374,264)(374,929)(358,677)
Total equity:610,620600,529576,606570,139549,518437,726
TOTAL LIABILITIES AND EQUITY:660,747648,985665,691659,353632,278514,088

Income Statement (P&L) ($ in thousands)

12/31/2023
Q4
9/30/2023
Q3
6/30/2023
Q2
3/31/2023
Q1
12/31/2022
Q4
9/30/2022
Q3
6/30/2022
Q2
Revenues93,10092,89470,65085,91870,38468,980
Cost of revenue
(Cost of Goods and Services Sold)
(23,996)(22,704)(18,150)(22,951)(19,124)(18,784)
Gross profit:69,10470,19052,50062,96751,26050,196
Operating expenses(69,791)(82,260)(66,866)(66,576)(67,635)(71,625)
Operating income (loss):(687)(12,070)(14,366)(3,609)(16,375)(21,429)
Nonoperating income (expense)4,1884,4244,3113,752(397)(479)
Investment income, nonoperating     1,501360
Other nonoperating income (expense)(83)174683 (1,898)(839)
Income (loss) from continuing operations before income taxes:3,501(7,646)(10,055)143(16,772)(21,908)
Income tax benefit427304807522520465
Income (loss) from continuing operations:3,928(7,342)(9,248)665(16,252)(21,443)
Loss before gain (loss) on sale of properties:(16,252)(21,443)
Net income (loss) available to common stockholders, diluted:3,928(7,342)(9,248)665(16,252)(21,443)

Comprehensive Income ($ in thousands)

12/31/2023
Q4
9/30/2023
Q3
6/30/2023
Q2
3/31/2023
Q1
12/31/2022
Q4
9/30/2022
Q3
6/30/2022
Q2
Net income (loss):3,928(7,342)(9,248)665(16,252)(21,443)
Comprehensive income (loss):3,928(7,342)(9,248)665(16,252)(21,443)
Other undisclosed comprehensive income (loss), net of tax, attributable to parent(6,185)3,7503,07111,038(12,057)(12,648)
Comprehensive income (loss), net of tax, attributable to parent:(2,257)(3,592)(6,177)11,703(28,309)(34,091)

Statements Sources

The financial statements are based on the Company's filings with the U.S. Securities and Exchange Commission (SEC) through the Electronic Data Gathering, Analysis, and Retrieval system (EDGAR). The information is derived from the 10-K and 10-Q reports submitted to the SEC in XBRL (eXtensible Business Reporting Language) format and presented according to the US GAAP Taxonomy. Please review the original filings for a more detailed information.

Login to ReadyRatios

 

Have you forgotten your password?

Are you a new user?

Login As
You can log in if you are registered at one of these services: